Momenta Pharmaceuticals
MNTA
#2337
Rank
โ‚ฌ5.75 B
Marketcap
48,41ย โ‚ฌ
Share price
0.00%
Change (1 day)
N/A
Change (1 year)

Revenue for Momenta Pharmaceuticals (MNTA)

Revenue in 2020 (TTM): โ‚ฌ27.07 Million

According to Momenta Pharmaceuticals's latest financial reports the company's current revenue is โ‚ฌ27.73 Million. In 2019 the company made a revenue of โ‚ฌ22.01 Million a decrease over the revenue in the year 2018 that were of โ‚ฌ69.72 Million. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.

Revenue history for Momenta Pharmaceuticals from 2004 to 2020

Annual revenue

Year Revenue Change
2020 (TTM)โ‚ฌ27.07 M23%
2019โ‚ฌ22.01 M-68.42%
2018โ‚ฌ69.72 M-45.57%
2017โ‚ฌ0.12 B26.7%
2016โ‚ฌ0.10 B22.28%
2015โ‚ฌ82.69 M71.58%
2014โ‚ฌ48.19 M47.33%
2013โ‚ฌ32.71 M-44.52%
2012โ‚ฌ58.96 M-77.42%
2011โ‚ฌ0.26 B142.41%
2010โ‚ฌ0.10 B476.68%
2009โ‚ฌ18.67 M38.97%
2008โ‚ฌ13.44 M-32.42%
2007โ‚ฌ19.88 M31.7%
2006โ‚ฌ15.09 M13.06%
2005โ‚ฌ13.35 M84.86%
2004โ‚ฌ7.22 M